Cargando…

Malignant hyperthermia mutations and correlation with the severity of the anesthetic complication and the level of the in vitro contracture tests

Detalles Bibliográficos
Autores principales:	Krivosic-Horber, René, Dalmas, Anne-Frédérique, Brasdefer, Etienne, Monnier, Nicole, Deken, Valérie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139668/ https://www.ncbi.nlm.nih.gov/pubmed/25749300 http://dx.doi.org/10.1186/1471-2253-14-S1-A1

Ejemplares similares

French guidelines for the management of malignant hyperthermia
por: Krivosic-Horber, René
Publicado: (2014)

Malignant hyperthermia testing in probands with NO adverse anesthetic reaction
por: Sterling, Carly, et al.
Publicado: (2014)

Analysis of malignant hyperthermia results in Padua and Siena
por: Tegazzin, Vincenzo, et al.
Publicado: (2014)

Malignant hyperthermia on ICU – sudden attack of the “snake”
por: Johannsen, Stephan, et al.
Publicado: (2014)

Accuracy of the diagnosis of malignant hyperthermia in hospital discharge records
por: Pinyavat, Teeda, et al.
Publicado: (2014)

Carnitine palmitoyltransferase 2 deficiency, malignant hyperthermia and anesthesia
por: Glauber, Violeta, et al.
Publicado: (2014)

Development and evolution of the MHAUS cognitive aid for malignant hyperthermia
por: Pinyavat, Teeda, et al.
Publicado: (2014)

Dantrolene in the treatment of malignant hyperthermia: a case report
por: Islander, Gunilla
Publicado: (2014)

Gene expression in the context of malignant hyperthermia status and ageing
por: Baines, Kathie Nicoll, et al.
Publicado: (2014)

Malignant hyperthermia as a rare cause of SIRS after cardiac surgery
por: Theuerkauf, Nils, et al.
Publicado: (2014)

Knowledge on malignant hyperthermia: as rare as the disease? A nation wide survey
por: Wolvetang, Timothy, et al.
Publicado: (2014)

Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility
por: Fiszer, Dorota, et al.
Publicado: (2014)

Preferential allele amplification leading to RyR1 misgenotyping in a malignant hyperthermia susceptible individual
por: Gonzalez, Asensio, et al.
Publicado: (2014)

Update of the quality assurance (QA) results of halothane and caffeine analysis of all current participating malignant hyperthermia units
por: Fisher, Nickla, et al.
Publicado: (2014)

Profile of malignant hyperthermia susceptibility reports confirmed with muscular contracture test in Brazil
por: Silva, Helga Cristina Almeida da, et al.
Publicado: (2019)

Effects of Theophylline on Anesthetized Malignant Hyperthermia-Susceptible Pigs
por: Fiege, Marko, et al.
Publicado: (2011)

Intra-operative post-induction hyperthermia, possibly malignant hyperthermia: Anesthetic implications, challenges and management
por: Gulabani, Michell, et al.
Publicado: (2014)

Intraoperative tachycardia, hypercapnia, hyperthermia and muscle stiffness in a dantrolene unavailability case. Can calcium channel blockers be valuable?
por: Marques, Acílio, et al.
Publicado: (2014)

Development of a malignant hyperthermia protocol
por: Yeung, EYH, et al.
Publicado: (2015)

Implementation of sonication and feedback control strategies for targeted hyperthermia in prostate with a commercial MR-guided endorectal ultrasound ablation array
por: Salgaonkar, Vasant, et al.
Publicado: (2015)

100 telephone conversations about malignant hyperthermia
por: Petersen, Bodil, et al.
Publicado: (2014)

Malignant hyperthermia and beyond - a virtual BioBank
por: Underwood, Rosie, et al.
Publicado: (2014)

fMRI correlates for low frequency local field potentials appear as a spatiotemporal dynamic under multiple anesthetic conditions
por: Thompson, Garth J, et al.
Publicado: (2012)

ERβ in normal and malignant breast
por: Gustafsson, J-Å, et al.
Publicado: (2005)

Management of infective endocarditis with cerebral complications
por: Fukuda, W, et al.
Publicado: (2013)

The molecular mechanisms underlying diabetic complications
por: Chiarelli, Francesco, et al.
Publicado: (2013)

Infectious complications in heart transplant patients
por: Ţilea, Brînduşa, et al.
Publicado: (2014)

Sonographic assessment of extent and aggressiveness of malignant breast disease
por: Stavros, T
Publicado: (2004)

Imaging of IPMN of the pancreas: evaluation of malignant potential and resectability
por: Lee, Jeong Min
Publicado: (2015)

Using structured reporting templates in staging pancreatic malignancies
por: Francis, Isaac R, et al.
Publicado: (2015)

Abdominal and pelvic complications of molecular targeted therapy
por: Gore, Richard M, et al.
Publicado: (2014)

Clinical management of patients with complicated multifocal disease
por: Gruenberger, Thomas
Publicado: (2014)

Complications following locoregional therapy of renal cancer
por: Krokidis, Miltiadis
Publicado: (2014)

Malignant hyperthermia
por: Rosenberg, Henry, et al.
Publicado: (2007)

Malignant hyperthermia
por: Kim, Dong-Chan
Publicado: (2012)

Inhibition of sarcoplasmic Ca(2+)-ATPase increases caffeine- and halothane-induced contractures in muscle bundles of malignant hyperthermia susceptible and healthy individuals
por: Schuster, Frank, et al.
Publicado: (2005)

Determinants of mTOR inhibitor therapy in AIDS-associated malignancies
por: Dittmer, Dirk P, et al.
Publicado: (2012)

Polychlorinated biphenyls (PCB), UV radiation, and cutaneous malignant melanoma
por: Gallagher, Richard P, et al.
Publicado: (2010)

MR visible only lesions: what are the predictors for malignant outcome?
por: Bhattacharyya, M, et al.
Publicado: (2010)

HIV/AIDS and health services: misaligned policy and maligned subjects
por: Amin, Aalya, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8ec94k7hq47g7ap369a6evgaif